Valuation: Danaher Corporation

Market Cap 16TCr 14TCr 13TCr 12TCr 22TCr 15,01300Cr 23TCr 1,56900Cr 61TCr 7,80700Cr 59TCr 58TCr 24,95900Cr P/E 2026 *
39.4x
P/E 2027 * 31.9x
Enterprise Value 18TCr 16TCr 15TCr 13TCr 25TCr 16,96800Cr 26TCr 1,77300Cr 69TCr 8,82400Cr 67TCr 66TCr 28,21000Cr EV / Sales 2026 *
6.77x
EV / Sales 2027 * 6.11x
Free-Float
70.44%
Yield 2026 *
0.62%
Yield 2027 * 0.67%
1 day+3.03%
1 week+5.95%
Current month+4.49%
1 month+13.90%
3 months+16.30%
6 months+16.56%
Current year+1.13%
1 week 216.51
Extreme 216.51
233.02
1 month 206.68
Extreme 206.675
233.02
Current year 160.93
Extreme 160.93
242.8
1 year 160.93
Extreme 160.93
242.8
3 years 160.93
Extreme 160.93
281.7
5 years 160.93
Extreme 160.93
331.68
10 years 75.71
Extreme 75.71
333.96
Manager TitleAgeSince
Chief Executive Officer - 01/10/2026
Director of Finance/CFO - 28/02/2026
Chief Tech/Sci/R&D Officer - 25/08/2025
Director TitleAgeSince
Director/Board Member 74 01/07/1999
Chairman 74 01/01/1984
Director/Board Member 69 01/01/1984
Date Insider Type Main position Quantity % Market Cap. Importance
01/10/26 Other

SVP, Chief Strategy Officer

59,816 0.0085% -
21/08/26 Sell

Chief Executive Officer

-58,255 0.0083%
04/08/26 Free

Chief Technology Officer

13,477 0.0019%
Change 5-day change 1-year change 3-year change Capi.($)
+3.03%+5.95%+12.30%+10.54% 16TCr
+3.46%+5.20%+32.46%+44.25% 25TCr
+1.81%+3.22%-1.95%+56.64% 15TCr
+2.65%+6.16%-54.14%-10.86% 6.23TCr
+1.95%+5.94%-12.00%-14.04% 4.96TCr
+1.91%+2.70%+20.09%+24.47% 4.98TCr
+5.27%+10.81%+8.82%+44.85% 4.81TCr
+0.89%+3.82%+27.17%+58.85% 4.91TCr
+1.73%+1.87%+33.32%+75.82% 4.29TCr
-1.41%+0.06%+194.43%+107.52% 4.1TCr
Average +2.13%+1.90%+26.05%+39.80% 8.98TCr
Weighted average by Cap. +2.54%+1.82%+19.96%+37.46%

Financials

2026 *2027 *
Net sales 2.64TCr 2.35TCr 2.18TCr 1.99TCr 3.74TCr 2,50500Cr 3.81TCr 26TCr 10TCr 1,30300Cr 9.89TCr 9.68TCr 4,16400Cr 2.85TCr 2.54TCr 2.35TCr 2.15TCr 4.04TCr 2,70700Cr 4.12TCr 28TCr 11TCr 1,40800Cr 11TCr 10TCr 4,50100Cr
Net income 417.95Cr 372.63Cr 345.5Cr 314.88Cr 592.83Cr 40TCr 603.88Cr 4.15TCr 1.63TCr 21TCr 1.57TCr 1.54TCr 66TCr 517.8Cr 461.66Cr 428.04Cr 390.11Cr 734.46Cr 49TCr 748.15Cr 5.14TCr 2.01TCr 26TCr 1.94TCr 1.9TCr 82TCr
Net Debt 2.06TCr 1.83TCr 1.7TCr 1.55TCr 2.92TCr 1,95500Cr 2.97TCr 20TCr 8TCr 1,01700Cr 7.72TCr 7.56TCr 3,25100Cr 1.62TCr 1.44TCr 1.34TCr 1.22TCr 2.29TCr 1,53700Cr 2.34TCr 16TCr 6.29TCr 80TCr 6.07TCr 5.94TCr 2,55600Cr
Projected Income Statement - Annual - Danaher Corporation
Logo Danaher Corporation
Danaher Corporation is an industrial and technologic group organized around three families of products: - diagnostic equipment (40.5% of net sales); - life sciences equipment (29.8%); - biotechnology equipment (29.7%): ranging from basic biological research to the development and manufacturing of vaccines, biological drugs, cell and gene therapies, and new technologies such as mRNA. Net sales are distributed geographically as follows: the United States (40.6%), China (10.7%) and other (48.7%).
Employees
59,000
Date Price Change Volume
15/26/15 $231.50 +3.03% 51,22,487
14/26/14 $224.69 +0.83% 35,96,732
13/26/13 $222.84 +0.74% 60,07,547
12/26/12 $221.20 +0.63% 30,04,435
09/26/09 $219.81 +1.08% 39,34,416
Trader
Investor
Global
Quality
ESG MSCI
A
MarketScreener Ratings - Danaher Corporation
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
25
Last Close Price
224.69USD
Average target price
244.14USD
Spread / Average Target
+8.65%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Danaher Corporation